Inter J Stomatol ›› 2013, Vol. 40 ›› Issue (6): 790-794.doi: 10.7518/gjkq.2013.06.024

Previous Articles     Next Articles

Commonly used surgical methods and progress in clinical treatment of Crouzon syndrome

Liu Lan, Zhang Kailiang, Yang Lan   

  1. Dept. of Oral and Maxillofacial Surgery, The Second Hospital of Lanzhou Uuniversity, Lanzhou 730030, China
  • Received:2013-03-28 Revised:2013-07-19 Online:2013-11-01 Published:2013-11-01

Abstract:

Crouzon syndrome is an autosomal dominant hereditary disease caused by craniosynostosis that is characterized by hypsicephaly and facial abnormalities such as surface central sag and exophthalmos. Treatment mainly includes surgery, physical therapy, and gene therapy. In particular, surgery is the primary treatment modality and it can be used for a variety of complications. Currently, surgical treatment is merely a remedy for Crouzon syndrome. Future clinical research will determine whether Crouzon syndrome can be diagnosed during embryonic development through gene technology, as well as preventing and blocking the occurrence of Crouzon syndrome through medical treatment. This paper reviews the progress on the surgical timing and treatment methods for Crouzon syndrome.

Key words: Crouzon syndrome, surgical method, gene therapy, advances

CLC Number: 

  • R 782.05

TrendMD: 
[1] Xu Yuanming, Fan Mingwen, Yang Xuechao. Application of mesenchymal stem cell in tumor targeted therapy [J]. Inter J Stomatol, 2013, 40(3): 371-374.
[2] Wang Cha, Xu Yan.. Effective releasing way of growth factors in periodontal tissue regeneration [J]. Inter J Stomatol, 2012, 39(2): 265-268.
[3] Luo Chuanxia1,2, Lin Zhengmei1.. Biological therapy for dentin-pulp complex regeneration and repair [J]. Inter J Stomatol, 2012, 39(1): 48-51.
[4] YANG Bin, ZHANG Zhiguang.. Research progress of gene therapy on temporomandibular joint osteoarthrosis [J]. Inter J Stomatol, 2010, 37(5): 608-612.
[5] LI Hao, HU Qin-gang.. Roles of VNP20009 in solid tumor therapy [J]. Inter J Stomatol, 2010, 37(4): 440-443.
[6] BU Tao, WANG Xu- xia. Safety assessment of adenoviral- mediated transfer of human bone morphogenetic protein gene [J]. Inter J Stomatol, 2008, 35(1): 41-43.
[7] SHI Pei-hua, HU Qin-gang.. Progress of RNA interfere in gene therapy for oral tumor [J]. Inter J Stomatol, 2007, 34(04): 281-283.
[8] DING Pei- hui, CHEN Li- li.. Periodontal Regener ation by Gene Ther apy [J]. Inter J Stomatol, 2007, 34(02): 97-99.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .